Position in GRFS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$224,560
-$37,240 QoQ
Shares Held
28,000
0.0% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
17 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GRFS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026FARALLON CAPITAL MANAGEMENT LLC holds $435,817,620 across 6 Drug Manufacturers - General names.
All Filings in GRFS
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $224,560 | 28,000 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $261,800 | 28,000 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $278,880 | 28,000 | Shares | Other | 2026-02-17 | |
| 2025-06-30 | $253,120 | 28,000 | Shares | Other | 2025-08-14 | |
| 2025-03-31 | $199,080 | 28,000 | Shares | Other | 2025-05-15 | |
| 2024-12-31 | $208,320 | 28,000 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $248,640 | 28,000 | Shares | Other | 2024-11-14 | |
| 2024-06-30 | $176,680 | 28,000 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $187,040 | 28,000 | Shares | Other | 2024-05-24 | |
| 2021-12-31 | $596,683 | 53,133 | Shares | Other | 2022-02-14 | |
| 2021-09-30 | $776,273 | 53,133 | Shares | Other | 2021-11-15 | |
| 2021-06-30 | $2,997,004 | 172,738 | Shares | Other | 2021-08-13 | |
| 2021-03-31 | $12,139,481 | 702,110 | Shares | Other | 2021-05-17 | |
| 2020-12-31 | $20,560,600 | 1,115,000 | Shares | Other | 2021-02-16 | |
| 2020-09-30 | $54,283,812 | 3,128,750 | Shares | Other | 2020-11-16 | |
| 2020-06-30 | $56,785,169 | 3,113,222 | Shares | Other | 2020-08-14 | |
| 2020-03-31 | $62,700,291 | 3,113,222 | Shares | Other | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||